Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 6Neoplasms 3Neoplasm Metastasis 2Liver Neoplasms 2Colorectal Neoplasms 2Solid Tumors 1Sarcoma 1Pyloric Stenosis, Hypertrophic 1Gastrointestinal Neoplasms 1Carcinoma, Transitional Cell 1Advanced Hepatocellular Carcinoma (HCC) 1Adenocarcinoma Of Esophagus 1

Interventions

Lenalidomide 2tafasitamab 1brivanib 1Valganciclovir 1N,N-dicyclopropyl-4-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-6-ethyl-1-methyl-1,6-dihydroimidazo(4,5-d)pyrrolo(2,3b)pyridine-7-carboxamide 1Leucovorin 1Irinotecan 1Fluorouracil 1Dexamethasone 1Bortezomib 1BMS-833923 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Pyloric Stenosis, Hypertrophic × brivanib × Clear all
NCT01046864 2014-09-16

Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)

Bristol-Myers Squibb

Phase 1 Completed
49 enrolled

Pyloric Stenosis, Hypertrophic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡